Pharmacokinetics of Ceftaroline in a Preterm Infant With Methicillin-Resistant Staphylococcus Aureus Pneumonia

Sara Salerno(University of California, San Francisco), Daniel González(University of North Carolina at Chapel Hill), Ravi Jhaveri, Matthew M. Laughon(University of North Carolina at Chapel Hill), Matthew M. Massaro(University of North Carolina at Chapel Hill), Janice Bernhardt(University of North Carolina at Chapel Hill)
Journal of the Pediatric Infectious Diseases Society
August 29, 2017
10.1093/jpids/pix084
Cited by 9

Related Papers

The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach
|American Journal of Respiratory and Critical Care Medicine|2019|1.2k
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
|Nature|2012|745
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232